HomeDrug recalls
Low severity

Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.

SourceFDA Drug Enforcement
CategoryDrug
SeverityLow
Statusongoing
Recall dateSeptember 12, 2025
ReportedOctober 29, 2025
Recalling firmJB Chemicals and Pharmaceuticals Ltd
Country / regionIndia U.S. Nationwide

Hazard

Tablet/Capsules Imprinted with Wrong ID

Affected products

Related recalls

Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASI · May 20, 2026Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo US · May 20, 2026Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: · May 20, 2026Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Lab · May 13, 2026DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialys · May 13, 2026